Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ejpb.2006.12.010
Title: Reversible effects of permeation enhancers on human skin
Authors: Kang, L. 
Poh, A.L.
Fan, S.K. 
Ho, P.C. 
Chan, Y.W.
Chan, S.Y. 
Keywords: Chemical enhancer
Haloperidol
Reversibility
Skin permeation
Terpene
Transdermal drug delivery
Issue Date: Aug-2007
Source: Kang, L., Poh, A.L., Fan, S.K., Ho, P.C., Chan, Y.W., Chan, S.Y. (2007-08). Reversible effects of permeation enhancers on human skin. European Journal of Pharmaceutics and Biopharmaceutics 67 (1) : 149-155. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ejpb.2006.12.010
Abstract: This study outlines a systematic approach for investigating a desired characteristic of chemicals used to facilitate the permeation of drugs across the skin that is, the reversibility of the permeation enhancement effect. This implies that the vital skin barrier function is restored and not permanently impaired after the application of these enhancers. The reversible effects of two terpene enhancers, (R)-(-)-carvone and eucarvone, on excised human skin were evaluated by in vitro permeation and extraction studies on normal (untreated) and enhancer-pretreated epidermis, respectively. For the permeation studies on normal epidermis, the donor solutions were the model drug, haloperidol (HP, 3 mg/ml), in propylene glycol (PG) with or without 5% (w/v) enhancer and for the extraction studies using epidermis pretreated with enhancer, a solution of HP (3 mg/ml) in PG was used. The solubilities of the enhancers in 0.03% lactic acid (receptor solution) and of HP in PG (donor solution) were determined to demonstrate that the sink and saturated conditions were maintained in the respective compartments of the flow-through cells throughout the in vitro experiments. (R)-(-)-Carvone cleared out of the skin faster than eucarvone. This could be due to the 4-fold higher skin permeability of (R)-(-)-carvone compared to that of eucarvone. The amount of HP deposited in the epidermis was much lower in the eucarvone-pretreated epidermis than that pretreated with (R)-(-)-carvone. The permeation profile of HP across the enhancer-pretreated skin was 4-fold greater than in the vehicle alone (control), but similar to that across untreated skin with enhancer present in the donor solution, indicating that permeation across the enhancer-pretreated skin did not change. The enhancing effects of both terpenes on the skin were found to be reversible and the permeability of the skin was left intact after the passage of the drug in the vehicle with these enhancers. © 2007 Elsevier B.V. All rights reserved.
Source Title: European Journal of Pharmaceutics and Biopharmaceutics
URI: http://scholarbank.nus.edu.sg/handle/10635/53135
ISSN: 09396411
DOI: 10.1016/j.ejpb.2006.12.010
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

18
checked on Dec 13, 2017

WEB OF SCIENCETM
Citations

15
checked on Nov 15, 2017

Page view(s)

42
checked on Dec 9, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.